• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

SVA ASX Appendix 4C - 31 March 2015PRICE SENSITIVE29/04/15
SVA Meeting documents23/04/15
SVA Disclosure under Listing Rule 3.10.5A22/04/15
SVA Results of Government SIM trial in DenmarkPRICE SENSITIVE20/04/15
SVA Simavita newsletter - April 201516/04/15
SVA Simavita grants executive options10/04/15
SVA Notice of initial substantial shareholder09/04/15
SVA Cleansing notice and ASX Appendix 3B09/04/15
SVA Simavita closes $8.3 million private placementPRICE SENSITIVE01/04/15
SVA Trading HaltPRICE SENSITIVE30/03/15
SVA Simavita investor presentation and video25/03/15
SVA Simavita progress updatePRICE SENSITIVE18/03/15
SVA Proposed appointment of new DirectorPRICE SENSITIVE13/03/15
SVA ASX Appendix 4D and financial statementsPRICE SENSITIVE27/02/15
SVA Receipt of $1.37 million R&D tax payment05/02/15
SVA CEO discusses recent announcements04/02/15
SVA ASX Appendix 4C - 31 December 2014PRICE SENSITIVE30/01/15
SVA Simavita signs up Danish distributorPRICE SENSITIVE29/01/15
SVA Release of securities from escrow20/01/15
SVA Simavita releases US investor presentation12/01/15
SVA Appointment of Chairman07/01/15
SVA Progress updatePRICE SENSITIVE06/01/15
SVA Results of 2014 Annual General and Special Meeting03/12/14
SVA 2014 AGM presentation materials03/12/14
SVA Financial results and MD&A - 30 September 201428/11/14
SVA 2014 Annual Report18/11/14
SVA Appointment of Craig Holland as DirectorPRICE SENSITIVE14/11/14
SVA Simavita Investor Newsletter November 201413/11/14
SVA Progress updatePRICE SENSITIVE03/11/14
SVA Appendix 4C - quarterlyPRICE SENSITIVE31/10/14
SVA 2014 Annual General and Special Meeting materials31/10/14
SVA Appendix 3B29/10/14
SVA Lorien Health Systems in US to roll out SIMPRICE SENSITIVE16/09/14
SVA Resignation of Chairman12/09/14
SVA CEO, Philippa Lewis discusses Financial Results & Update04/09/14
SVA ASX Appendix 4E and audited Financial ReportPRICE SENSITIVE28/08/14
SVA ASX Appendix 3B27/08/14
SVA Progress update - 19 August 2014PRICE SENSITIVE19/08/14
SVA Significant shareholder disclosure07/08/14
SVA Appendix 3Y - Damien Haakman01/08/14
SVA Appendix 3Y - Peter Cook01/08/14
SVA Appendix 3Y - Ari Bergman01/08/14
SVA Appendix 3Y - Philippa Lewis31/07/14
SVA ASX Appendix 3B30/07/14
SVA ASX Appendix 4CPRICE SENSITIVE25/07/14
SVA Results of Special Meeting23/07/14
SVA Simavita presents at Bioshares Biotech Summit, New Zealand18/07/14
SVA Progress updatePRICE SENSITIVE01/07/14
SVA Cleansing notice and ASX Appendix 3B30/06/14
SVA ASX Appendix 4FPRICE SENSITIVE30/06/14
SVA Meeting documents and SPP offer document26/06/14
SVA Capital raising updatePRICE SENSITIVE23/06/14
SVA Trading HaltPRICE SENSITIVE19/06/14
SVAInvestor newsletter02/06/14
SVAInterim financial statements and MD&A - 31 March 201402/06/14
SVAResponse to ASX Price QueryPRICE SENSITIVE16/05/14
SVAASX Appendix 4CPRICE SENSITIVE29/04/14
SVAChange of balance date23/04/14
SVAUpdate on recent progressPRICE SENSITIVE22/04/14
SVAASX Appendix 3Z17/04/14
SVAAustralian Roadshow Presentation19/03/14
SVAAppendix 4C - 31 January 2014PRICE SENSITIVE03/03/14
SVAInterim financial statements - 31 December 201303/03/14
SVAChanges to Board and Management28/02/14
SVASimavita Investor Presentation20/02/14
SVASimavita CEO discusses today's ASX Listing20/02/14
SVAForeign Entity Statement19/02/14
SVAStatement of Restricted Securities19/02/14
SVACorporate Governance Policy19/02/14
SVACorporate Governance Statement19/02/14
SVAFull Terms and Conditions of Warrants19/02/14
SVAStock Option Plan19/02/14
SVAUpdated Capital Structure19/02/14
SVAUpdated Pro-Forma Statement of Financial Position19/02/14
SVAUpdated Statement of Commitments19/02/14
SVAGtech International Resources Limited Unaudited FS 31July1319/02/14
SVAGtech International Resources Limited Financial Report 201319/02/14
SVAGtech International Resources Limited Financial Report 201219/02/14
SVAGtech International Resources Limited Financial Report 201119/02/14
SVASimavita Holdings Limited Financial Report 201319/02/14
SVASimavita Holdings Limited Financial Report 201219/02/14
SVASimavita Holdings Limited Financial Report 201119/02/14
SVASimavita Limited Unaudited Financial Statements 31 Oct 1319/02/14
SVASimavita Limited Articles19/02/14
SVAAppendix 1A and Information Form and Checklist19/02/14
SVATop 20 Holders19/02/14
SVADistribution Schedule19/02/14
SVAPre-Quotation Disclosure19/02/14
SVAASX Notice - Admission and Commencement of Quotation19/02/14
SVAAdmission to the Official ListPRICE SENSITIVE19/02/14
SVAReplacement Prospectus19/02/14
SVA ASX Appendix 4C - 31 March 2015
29/04/15PRICE SENSITIVE
SVA Meeting documents
23/04/15
SVA Disclosure under Listing Rule 3.10.5A
22/04/15
SVA Results of Government SIM trial in Denmark
20/04/15PRICE SENSITIVE
SVA Simavita newsletter - April 2015
16/04/15
SVA Simavita grants executive options
10/04/15
SVA Notice of initial substantial shareholder
09/04/15
SVA Cleansing notice and ASX Appendix 3B
09/04/15
SVA Simavita closes $8.3 million private placement
01/04/15PRICE SENSITIVE
SVA Trading Halt
30/03/15PRICE SENSITIVE
SVA Simavita investor presentation and video
25/03/15
SVA Simavita progress update
18/03/15PRICE SENSITIVE
SVA Proposed appointment of new Director
13/03/15PRICE SENSITIVE
SVA ASX Appendix 4D and financial statements
27/02/15PRICE SENSITIVE
SVA Receipt of $1.37 million R&D tax payment
05/02/15
SVA CEO discusses recent announcements
04/02/15
SVA ASX Appendix 4C - 31 December 2014
30/01/15PRICE SENSITIVE
SVA Simavita signs up Danish distributor
29/01/15PRICE SENSITIVE
SVA Release of securities from escrow
20/01/15
SVA Simavita releases US investor presentation
12/01/15
SVA Appointment of Chairman
07/01/15
SVA Progress update
06/01/15PRICE SENSITIVE
SVA Results of 2014 Annual General and Special Meeting
03/12/14
SVA 2014 AGM presentation materials
03/12/14
SVA Financial results and MD&A - 30 September 2014
28/11/14
SVA 2014 Annual Report
18/11/14
SVA Appointment of Craig Holland as Director
14/11/14PRICE SENSITIVE
SVA Simavita Investor Newsletter November 2014
13/11/14
SVA Progress update
03/11/14PRICE SENSITIVE
SVA Appendix 4C - quarterly
31/10/14PRICE SENSITIVE
SVA 2014 Annual General and Special Meeting materials
31/10/14
SVA Appendix 3B
29/10/14
SVA Lorien Health Systems in US to roll out SIM
16/09/14PRICE SENSITIVE
SVA Resignation of Chairman
12/09/14
SVA CEO, Philippa Lewis discusses Financial Results & Update
04/09/14
SVA ASX Appendix 4E and audited Financial Report
28/08/14PRICE SENSITIVE
SVA ASX Appendix 3B
27/08/14
SVA Progress update - 19 August 2014
19/08/14PRICE SENSITIVE
SVA Significant shareholder disclosure
07/08/14
SVA Appendix 3Y - Damien Haakman
01/08/14
SVA Appendix 3Y - Peter Cook
01/08/14
SVA Appendix 3Y - Ari Bergman
01/08/14
SVA Appendix 3Y - Philippa Lewis
31/07/14
SVA ASX Appendix 3B
30/07/14
SVA ASX Appendix 4C
25/07/14PRICE SENSITIVE
SVA Results of Special Meeting
23/07/14
SVA Simavita presents at Bioshares Biotech Summit, New Zealand
18/07/14
SVA Progress update
01/07/14PRICE SENSITIVE
SVA Cleansing notice and ASX Appendix 3B
30/06/14
SVA ASX Appendix 4F
30/06/14PRICE SENSITIVE
SVA Meeting documents and SPP offer document
26/06/14
SVA Capital raising update
23/06/14PRICE SENSITIVE
SVA Trading Halt
19/06/14PRICE SENSITIVE
SVAInvestor newsletter
02/06/14
SVAInterim financial statements and MD&A - 31 March 2014
02/06/14
SVAResponse to ASX Price Query
16/05/14PRICE SENSITIVE
SVAASX Appendix 4C
29/04/14PRICE SENSITIVE
SVAChange of balance date
23/04/14
SVAUpdate on recent progress
22/04/14PRICE SENSITIVE
SVAASX Appendix 3Z
17/04/14
SVAAustralian Roadshow Presentation
19/03/14
SVAAppendix 4C - 31 January 2014
03/03/14PRICE SENSITIVE
SVAInterim financial statements - 31 December 2013
03/03/14
SVAChanges to Board and Management
28/02/14
SVASimavita Investor Presentation
20/02/14
SVASimavita CEO discusses today's ASX Listing
20/02/14
SVAForeign Entity Statement
19/02/14
SVAStatement of Restricted Securities
19/02/14
SVACorporate Governance Policy
19/02/14
SVACorporate Governance Statement
19/02/14
SVAFull Terms and Conditions of Warrants
19/02/14
SVAStock Option Plan
19/02/14
SVAUpdated Capital Structure
19/02/14
SVAUpdated Pro-Forma Statement of Financial Position
19/02/14
SVAUpdated Statement of Commitments
19/02/14
SVAGtech International Resources Limited Unaudited FS 31July13
19/02/14
SVAGtech International Resources Limited Financial Report 2013
19/02/14
SVAGtech International Resources Limited Financial Report 2012
19/02/14
SVAGtech International Resources Limited Financial Report 2011
19/02/14
SVASimavita Holdings Limited Financial Report 2013
19/02/14
SVASimavita Holdings Limited Financial Report 2012
19/02/14
SVASimavita Holdings Limited Financial Report 2011
19/02/14
SVASimavita Limited Unaudited Financial Statements 31 Oct 13
19/02/14
SVASimavita Limited Articles
19/02/14
SVAAppendix 1A and Information Form and Checklist
19/02/14
SVATop 20 Holders
19/02/14
SVADistribution Schedule
19/02/14
SVAPre-Quotation Disclosure
19/02/14
SVAASX Notice - Admission and Commencement of Quotation
19/02/14
SVAAdmission to the Official List
19/02/14PRICE SENSITIVE
SVAReplacement Prospectus
19/02/14
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.